Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease

Background and objectives: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, reduces bioavailability of nitric oxide and induces endothelial dysfunction. This dimethylated amino acid accumulates in chronic kidney disease and may be involved in the pathophysiology...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Young, Jill Melendez, Terrin, Norma, Wang, Xuelei, Greene, Tom, Beck, Gerald J., Kusek, John W., Collins, Allan J., Sarnak, Mark J., Menon, Vandana
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Nephrology 2009
Assuntos:
Epidemiology and Outcomes
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2689879/
https://ncbi.nlm.nih.gov/pubmed/19389824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06671208
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares